A speech prosthetic developed by researchers in the US can translate brain signals into words, and could one day enable people with neurological disorders to regain...
Professor Dame Pamela Shaw joins to help advance development of its ALS/MND drug candidate SAM001
NR Times reports on the much-anticipated trial of ALS treatment AMX0035, in an interview with Machelle Manuel, head of global medical affairs at its creator Amylyx. Recently...
NR Times meets Coya Therapeutics’ founder and CEO Howard Berman as he closes in on his mission to halt ALS / motor neurone disease and other...
How husband's passing inspired a movement in neurological health.
Calls made as research reveals diagnosis of a genetic cause of ALS in hundreds of people could be missed due to rules around testing
New research reveals the potential of the drug terazosin in supporting those with motor neuron disease
Thousands of people could be living without diagnosis of the motor neuron disease, research reveals
Johns Hopkins researchers have identified a potential window for treating the neurodegenerative disease
The Precision ALS programme will result in advanced, data-driven prediction models for progression of MND, say researchers
